Back to results
US 2025/0146085 A1Published application
Methods for early detection of cancer
AssigneeGuardant Health, Inc.
InventorsStefanie Ann Ward MORTIMER, AmirAli TALASAZ, Darya CHUDOVA, Helmy ELTOUKHY
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods, compositions, and devices for use in the early detection of cancer. The methods include preparing cell-free nucleic acid molecules from a subject for sequencing, sequencing a panel of regions in the cell-free nucleic acid molecules, and detecting one or more markers that are indicative of a cancer.
Claims27
A method for detecting residual cancer after surgery by interrogating methylation status and genetic variants in cell-free deoxyribonucleic acid (cfDNA) molecules of a sample from a subject, the method comprising:
- (a) enriching the cfDNA molecules or amplicons thereof using oligonucleotide sequence capture probes for a plurality of genes or genomic regions, wherein the plurality of genes or genomic regions:
- (i) comprise CpG islands which are differentially methylated regions, and
- (ii) are known to be associated with one or more cancers;
- (b) sequencing a plurality of enriched cfDNA molecules or enriched amplicons thereof to generate sequencing data;
- and
- (c) determining methylation profiles of the cfDNA molecules from the sequencing data and further detecting a presence or absence of one or more genetic variants in cfDNA molecules in the sample to detect the presence or absence of residual disease in the subject.
3 more elements
Dependencies are inferred from the claim text.